Laboratory Investigation
United States and Canadian Academy of Pathology The United States and Canadian Academy of Pathology
LWW Lippincott Williams and Wilkins
publishes Laboratory Investigation
--
                                      View Future Titles
Through Mar 2001
       Archives
Aug 1965 - Feb 2001
       Search Articles
Aug 1965 - Feb 2001
       Browse by Subject
Aug 1965 - Feb 2001
                      
Instructions to authors

Subscriptions

About the journal
   
  Reduced Cadherin/Catenin Complex Expression in Celiac Disease Can Be Reproduced In Vitro by Cytokine Stimulation
Editorial board

Email alerts

'Net Tips

Help

Feedback

Guestbook








  Ian Perry, Chris Tselepis, Judith Hoyland, Tariq H. Iqbal, D. Scott A. Sanders, Brian T. Cooper, and Janusz A. Z. Jankowski
   
  Institute for Cancer Studies and Department of Medicine (IP, CT, JAZJ), University of Birmingham, Birmingham, United Kingdom; Gastroenterology Unit (IP, THI, BTC), City Hospital, Birmingham, United Kingdom; Department of Histopathology (DSAS), Queen Elizabeth Hospital, Birmingham, United Kingdom; and Musculoskeletal Research Group (JH), University of Manchester, Manchester, United Kingdom
   
  SUMMARY: Celiac disease is characterized by a chronic immune response to dietary gluten, in which T cell responses result in elevated mucosal levels of tumor necrosis factor (TNF)-[alpha], interleukin (IL)-1, interferon (IFN)-[gamma], and transforming growth factor (TGF)-[beta], which induce profound mucosal remodeling associated with increased enterocyte proliferation, apoptosis, and migration. Reduced intestinal expression of the morphoregulatory cell adhesion molecule E-cadherin, which forms complexes with [beta]-catenin, can increase enterocyte proliferation and migration. However, its mechanism of action in gastrointestinal inflammatory conditions and any involvement in celiac disease is unknown. In this study, we describe changes in E-cadherin and [beta]-catenin expression in celiac disease tissue and determine the effect of cytokines on their expression in an in vitro model. We assessed E-cadherin and [beta]-catenin expression in intestinal biopsies from 24 patients with celiac disease, 12 patients with treated celiac disease, and 10 healthy patients by immunohistochemistry, Western blotting, and confocal microscopy. Using Caco-2 cells, we examined the effect of TNF-[alpha], IL-1, IFN-[gamma], and TGF-[beta] on E-cadherin expression. E-cadherin transcription was assessed in both intestinal biopsies and Caco-2 cells by in situ hybridization and RT-PCR, respectively. A marked reduction in protein expression of E-cadherin and [beta]-catenin that returns to normal levels after treatment was observed in celiac disease; this reduction was associated with reduced levels of E-cadherin mRNA. E-cadherin expression in Caco-2 cells was significantly reduced after TNF-[alpha], IL-1, and IFN-[gamma] stimulation. The effect of TNF-[alpha] on E-cadherin expression was maximal after stimulation for 48 hours and also induced modest reductions in [beta]-catenin expression. The action of TNF-[alpha] on E-cadherin was reversible and was shown to act at the transcriptional level. These results demonstrate the novel findings that E-cadherin and [beta]-catenin expression are reversibly down-regulated in celiac disease and that such changes in epithelial cadherin/catenin complexes may be mediated by cytokines acting on cadherin transcription.